Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05821777
Title A Study to Evaluate Safety, Tolerability and Preliminary Activity of LB101 in Participants With Advanced Solid Tumors
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Centessa Pharmaceuticals (UK) Limited
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA

Facility Status City State Zip Country Details
Sarah Cannon Research Institute at HealthONE. RECRUITING Denver Colorado 80218 United States Details
Sarah Cannon Research Institute at Florida Cancer Specialists RECRUITING Sarasota Florida 34232 United States Details
Memorial Sloan Kettering Cancer Center RECRUITING New York New York 10065 United States Details
Sarah Cannon Research Institute at Tennessee Oncology Nashville RECRUITING Nashville Tennessee 37203 United States Details
NEXT Oncology - Dallas RECRUITING Irving Texas 75039 United States Details
NEXT Oncology RECRUITING San Antonio Texas 78229 United States Details
Institut Gustave Roussy RECRUITING Villejuif 94805 France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field